IR-MED Awarded Most Innovative Non-Invasive Diagnostics Technology Developer 2023 by Corporate Vision Magazine PressureSafe, for the early detection of pressure injuries, addresses a healthcare challenge that costs $26.8 billion and causes 60,000 deaths annually in the U.S. alone Non-invasive device to augment...

IR-MED SIGNS AGREEMENT TO EXPAND ITS PRESSURESAFE DEVICE USABILITY STUDY The study will expand to Rabin Medical Center (RMC), in parallel to Beit-Rivka, turning the study to a double center usability study. Rosh Pinna, Israel, Feb. 14, 2023 (GLOBE NEWSWIRE) --...

IRME Letter to Shareholders New York, N.Y., Jan. 11, 2022 (GLOBE NEWSWIRE) -- IR-Med, Inc. (OTCPINK: IRME). Our non-invasive monitoring technology enters the public eye – why I’m so excited for 2022. Dear new, old, and...

IR-Med to Become Fully Reporting SEC Company IR-Med filed an application to uplist to OTCQB New York, N.Y., Nov. 12, 2021 (GLOBE NEWSWIRE) -- IR-Med, Inc. (OTCPINK: IRME), a development stage medical device company that utilizes Infra-Red...

IR-Med, Inc. Announces the Appointment of Dr. Rom Eliaz as Chief Executive Officer New York, NY, June 25, 2021 (GLOBE NEWSWIRE) -- IR-Med, Inc. (OTCPINK: IRME) announced today the appointment of Dr. Rom Eliaz as Chief Executive Officer. Prior to his appointment as our CEO, Dr....